DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Orexigen: Contrave Sales Win The Week, Pace Still Slower Than Needed

Arena - Belviq Sales Slide Again

Vivus- Qsymia Sales Dip And Flatten Out

Novo Nordisk: Anti-Obesity Treatment Saxenda Passes 1,000 Scripts

Obesity Statistics Take a Wrong Turn in This Latest Study

Obesity, the silent killer, costs the global economy $2 trillion annually. Find out what tactics could be used to help curb rising obesity levels.

Arena - Belviq Advertising Report For June

Arena Pharmaceuticals (ARNA): Today's Weak On High Volume Stock

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume

Orexigen: Contrave Sales Lead The Sector, But Need Improvement

See More Articles...